REG - Marshall Wace LLP Takeda Pharma.Co.Ltd - Form 8.3 - Takeda Pharmaceutical Co Ltd

Takeda Pharmaceutical CoAnnouncement

31/12/2018 12:30

RNS Number : 8434L
Marshall Wace LLP
31 December 2018
 


FORM 8.3
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Full name of discloser:


Marshall Wace LLP (on behalf of itself and its affiliates)




(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.








(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:








(e) Date position held/dealing undertaken:
     For an opening position disclosure, state the latest practicable date prior to the disclosure


28 Dec 2018




(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
     If it is a cash offer or possible cash offer, state "N/A"


YES
If YES, specify which:
Shire plc



 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



Class of relevant security:
 


Ordinary shares (ISIN: JP3463000004) - interest and short positions partially held via ADSs (ISIN: US8740602052)




 
 


Interests


Short positions








Number


%


Number


%




(1) Relevant securities owned and/or controlled:


1,776,275


0.23%


838,443


0.11%




(2) Cash-settled derivatives:
 










1,202,772


0.15%




(3) Stock-settled derivatives (including options) and agreements to purchase/sell:




















 
     TOTAL:


1,776,275


0.23%


2,041,215


0.26%



 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



Class of relevant security in relation to which subscription right exists:








Details, including nature of the rights concerned and relevant percentages:







 
 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
(a)        Purchases and sales
 



Class of relevant security


Purchase/sale
 


Number of securities


Price per unit




Ordinary Shares


Sale


134


JPY 3750




Ordinary Shares


Sale


1,971


JPY 3757.1225




Ordinary Shares


Sale


6,110


JPY 3748.677




Ordinary Shares


Purchase


36,200


JPY 3739.1727




Ordinary Shares


Sale


63,300


JPY 3740.7512




Ordinary Shares


Sale


271


JPY 3721.3226




Ordinary Shares


Sale


2,382


JPY 3751.9886




Ordinary Shares


Sale


3,917


JPY 3711.7207




Ordinary Shares


Sale


5,099


JPY 3746.3851




Ordinary Shares


Sale


1,433


JPY 3717.8581




Ordinary Shares


Sale


10,708


JPY 3714.5697




Ordinary Shares


Sale


6,675


JPY 3745.2659




Ordinary Shares


Sale


2,179


JPY 3729.2264




Ordinary Shares


Sale


49,121


JPY 3730.6248




Ordinary Shares


Sale


200


USD 33




ADS


Sale


300


USD 16.7




ADS


Sale


600


USD 16.75




ADS


Sale


800


USD 16.76875




ADS


Sale


232


USD 16.8286



 
(b)        Cash-settled derivative transactions
 



Class of relevant security


Product description
e.g. CFD


Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit




Ordinary Shares


CFD


Reducing a short position


47,000


JPY 3741




Ordinary Shares


CFD


Increasing a short position


66


JPY 3750




Ordinary Shares


CFD


Increasing a short position


129


JPY 3743.5




Ordinary Shares


CFD


Increasing a short position


1,490


JPY 3751.331117




Ordinary Shares


CFD


Increasing a short position


19,900


JPY 3738.467337




Ordinary Shares


CFD


Increasing a short position


529


JPY 3720.456657




Ordinary Shares


CFD


Increasing a short position


2,318


JPY 3741.657959




Ordinary Shares


CFD


Increasing a short position


8,983


JPY 3710.74141




Ordinary Shares


CFD


Increasing a short position


4,901


JPY 3729.010883




Ordinary Shares


CFD


Increasing a short position


2,967


JPY 3711.631062




Ordinary Shares


CFD


Increasing a short position


22,192


JPY 3710.95609




Ordinary Shares


CFD


Increasing a short position


8,525


JPY 3722.070364




Ordinary Shares


CFD


Increasing a short position


3,721


JPY 3719.918192




Ordinary Shares


CFD


Increasing a short position


88,979


JPY 3716.477812



 
(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



Class of relevant security


Product description e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type
e.g. American, European etc.


Expiry date


Option money paid/ received per unit





































 
(ii)        Exercise
 



Class of relevant security


Product description
e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit




















 
 



 
(d)        Other dealings (including subscribing for new securities)
 



Class of relevant security


Nature of dealing
e.g. subscription, conversion


Details


Price per unit (if applicable)








 
 











 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(b)        Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
 
 



 
(c)        Attachments
 



Is a Supplemental Form 8 (Open Positions) attached?


NO



 
 



Date of disclosure:


31 Dec 2018




Contact name:


Matthew Rooney




Telephone number:


020 7316 2253



 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETBDBDDRDXBGIB